Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

Penile Implant Brands

Coloplast Titan & Boston Scientific AMS 700 inflatable prostheses

Evidence grade 5 of 5, Settled. Read how the Atlas grades evidence.

The written rationale for this grade is still being prepared.

FDA
FDA Approved (inflatable penile prostheses)

Reference only. Not medical advice.

What can go wrong

Surgical risks include infection (device explant if infected), mechanical failure over years, erosion, and the irreversible destruction of native erectile tissue (after an IPP, non-device erections are generally no longer possible). Infection rates are ~1-3% for first-time implants but higher (cited up to 7-18%) in revision cases. Diabetics and revisions carry elevated infection risk.

This is something to take to a clinician. The Atlas can tell you what is known about penile implant brands in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.

The inflatable penile prosthesis (IPP) market is a near-duopoly: Boston Scientific's AMS 700 and Coloplast's Titan dominate three-piece device sales. An IPP is the definitive surgical treatment for ED that fails other therapies; published partner and patient satisfaction rates are among the highest of any ED intervention (commonly 80-95%+). The two brands differ in cylinder design, pump ergonomics, and coatings, but systematic reviews report broadly comparable satisfaction.

A two-company market with the highest satisfaction scores in ED care.

What people take it for

What it is taken for. Approval, where it exists, covers only some of these.

  • Definitive treatment for refractory ED
  • Post-prostatectomy ED
  • Severe vasculogenic or diabetic ED
  • Peyronie's with ED

How it works

A three-piece IPP places two inflatable cylinders in the corpora cavernosa, a fluid reservoir in the pelvis/abdomen, and a scrotal pump. Squeezing the pump moves saline from the reservoir into the cylinders to create rigidity; a release valve returns the fluid for flaccidity. It mechanically replaces the erectile mechanism and is independent of blood flow or nerve signaling.

Safety in detail

Penile prosthesis implantation is an irreversible surgical procedure that destroys the native erectile tissue and requires evaluation and follow-up by a qualified surgeon. It carries documented risks of infection, mechanical failure, and erosion.

What people get wrong

  • Often saidAn implant is the first thing to try for ED

    ActuallyAn IPP is reserved for men who fail or cannot use less invasive therapies. It is definitive but irreversible, native erections do not return after surgery.

Who profits, and who pushes back

Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.

How we got here

The modern inflatable penile prosthesis was pioneered by F. Brantley Scott and American Medical Systems (AMS) in 1973. AMS's urology line was acquired by Boston Scientific (2015), becoming the AMS 700. Coloplast entered via acquisition of Mentor's urology business, marketing the Titan. Decades of iteration improved coatings (to cut infection) and pump ergonomics.

  1. 1973Scott/AMS introduce the first inflatable penile prosthesis
  2. 2000sAntibiotic and hydrophilic coatings reduce infection
  3. 2015Boston Scientific acquires AMS urology (AMS 700)
  4. 2020sAMS 700 and Coloplast Titan dominate the IPP market

Set against the alternatives

Boston Scientific AMS 700 features the MS (momentary squeeze) pump and InhibiZone antibiotic coating; Coloplast Titan features a hydrophilic coating that absorbs antibiotic dip and the one-touch-release pump. Systematic literature review (Cureus/PubMed, 2020) found comparable satisfaction between AMS 700 and Titan, with some series reporting slightly lower AMS dissatisfaction; differences are device-design, not class-level.

At a glance

Dominant brands
Boston Scientific AMS 700, Coloplast Titan
Device type
Three-piece inflatable (cylinders, pump, reservoir)
Virgin-implant infection rate
~1-3% (lower with antibiotic/hydrophilic coatings & 'no-touch' technique)
Satisfaction
Commonly 80-95%+ patient/partner in published series

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about Penile Implant Brands. A short entry is not a safe entry.

  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • Children and teenagers. We have not checked what is known about younger people.
  • Where we land. We have not taken a position on this yet.

Sources

The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.

The studies that matter

  • Systematic review: AMS 700 vs Coloplast Titan2020

    Comparable patient satisfaction (roughly mid-70s% range in pooled data) with no significant overall difference between brands